PDT Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-121,517
| Closed | -$1.82M | – | 550 |
|
|
2025
Q3 | $1.82M | Sell |
121,517
-150,786
| -55% | -$1.84M | 0.11% | 272 |
|
|
2025
Q2 | $3.17M | Sell |
272,303
-72,675
| -21% | -$660K | 0.18% | 199 |
|
|
2025
Q1 | $2.56M | Buy |
344,978
+28,697
| +9% | +$221K | 0.18% | 190 |
|
|
2024
Q4 | $1.9M | Buy |
316,281
+35,899
| +13% | +$198K | 0.17% | 218 |
|
|
2024
Q3 | $1.44M | Buy |
280,382
+65,378
| +30% | +$285K | 0.13% | 292 |
|
|
2024
Q2 | $778K | Hold |
215,004
| – | – | 0.07% | 389 |
|
|
2024
Q1 | $690K | Buy |
215,004
+98,200
| +84% | +$380K | 0.07% | 399 |
|
|
2023
Q4 | $572K | Buy |
116,804
+100,845
| +632% | +$460K | 0.06% | 383 |
|
|
2023
Q3 | $87K | Sell |
15,959
-110,384
| -87% | -$730K | 0.01% | 556 |
|
|
2023
Q2 | $848K | Buy |
126,343
+18,684
| +17% | +$139K | 0.12% | 286 |
|
|
2023
Q1 | $951K | Buy |
107,659
+16
| +0% | +$141 | 0.13% | 273 |
|
|
2022
Q4 | $822K | Buy |
107,643
+54,318
| +102% | +$423K | 0.13% | 279 |
|
|
2022
Q3 | $380K | Sell |
53,325
-6,568
| -11% | -$61.9K | 0.06% | 515 |
|
|
2022
Q2 | $485K | Sell |
59,893
-359
| -0.6% | -$3.16K | 0.04% | 612 |
|
|
2022
Q1 | $836K | Sell |
60,252
-24,048
| -29% | -$378K | 0.07% | 425 |
|
|
2021
Q4 | $2.37M | Sell |
84,300
-13,572
| -14% | -$416K | 0.18% | 204 |
|
|
2021
Q3 | $3.33M | Buy |
97,872
+2,068
| +2% | +$74.8K | 0.24% | 186 |
|
|
2021
Q2 | $3.92M | Buy |
95,804
+1,288
| +1% | +$50.1K | 0.26% | 185 |
|
|
2021
Q1 | $3.81M | Sell |
94,516
-14,443
| -13% | -$782K | 0.27% | 141 |
|
|
2020
Q4 | $6.44M | Sell |
108,959
-59,048
| -35% | -$3.04M | 0.44% | 40 |
|
|
2020
Q3 | $8.17M | Buy |
168,007
+157,594
| +1,513% | +$6.62M | 0.54% | 30 |
|
|
2020
Q2 | $504K | Buy |
+10,413
| New | +$380K | 0.03% | 408 |
|
Other funds holding ADPT
